華大基因(300676.SZ):與潤達醫療簽署戰略合作協議 推進精準檢測技術在醫療體系應用前移
格隆匯 8 月 21日丨華大基因(300676.SZ)公佈,公司於2020 年8月21日與潤達醫療在上海市簽署了《戰略合作協議》。為推進精準檢測技術在醫療體系應用前移,從疾病診斷轉向預防為主,服務中國民生健康,協議雙方決定按照“合作共贏、優勢互補、共同發展”的原則,依託各自資源和技術優勢,建立全面戰略合作關係。
華大基因作為全球領先的科學技術服務提供商和精準醫療服務運營商,聚焦“基因與健康”領域,致力於將前沿的基因領域科研成果及生物技術應用於民生健康等相關領域。潤達醫療以信息化、數據化技術為支撐,為各類醫學實驗室提供體外診斷產品、技術服務支持、實驗室運營管理等全方位的綜合服務,並根據各類型醫療機構的個性化需求,致力於為其提供量身定製的整體解決方案服務。
該協議的簽署旨在充分發揮雙方各自優勢,資源共享,協同合作,協助各級醫療機構建立相關精準檢測平台,推動社會公共衞生平台及科研平台的建設,助力精準醫學的研究與發展,為“預防為主、服務民生”的新醫療健康體系提供強有力的技術和平台支撐。公司與潤達醫療建立的戰略合作,符合公司的整體戰略佈局與業務發展,將進一步拓展基因科技造福人類的業務領域,更好地服務民生健康。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.